Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.05
-0.17 (-3.26%)
Sep 8, 2026, 12:20 PM EDT - Market open

Champions Oncology Revenue

In the fiscal year ending April 30, 2026, Champions Oncology had annual revenue of $59.43M with 4.36% growth. Champions Oncology had revenue of $13.84M in the quarter ending April 30, 2026, with 11.98% growth.

Revenue (ttm)
$59.43M
Revenue Growth
+4.36%
P/S Ratio
1.22
Revenue / Employee
$277,687
Employees
214
Market Cap
70.16M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202659.43M2.48M4.36%
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 202032.12M5.06M18.68%
Apr 30, 201927.07M6.83M33.72%
Apr 30, 201820.24M4.83M31.34%
Apr 30, 201715.41M--
Apr 30, 2016---
Apr 30, 2015---
Apr 30, 2014---
Apr 30, 2013---
Apr 30, 2012---
Apr 30, 2011---
Apr 30, 2010---
Apr 30, 20093.71M2.31M165.00%
Apr 30, 20081.40M--
Apr 30, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Spero Therapeutics47.00M
NeurAxis5.32M
Nutriband1.62M
BioRestorative Therapies357.87K
Serina Therapeutics130.00K
INmune Bio50.00K
Revenue Rankings

CSBR News

More News